Naphcon-A (pheniramine-naphazoline) is filed as Ophthalmic Decongestant/Antihistamine. The sections below restate public label fields stored for this profile.
Uses for the temporary relief of redness and itching of the eye(s) due to: ragweed pollen grass animal dander and hair
Warnings For external use only
Directions adults and children 6 years and over: put 1 or 2 drops in the affected eye(s) up to 4 times daily children under 6 years: ask a doctor
According to its FDA label, Naphcon-A (pheniramine-naphazoline) is approved for: Uses for the temporary relief of redness and itching of the eye(s) due to: ragweed pollen grass animal dander and hair For medical advice, please talk to your prescriber or pharmacist.
Naphcon-A (pheniramine-naphazoline) belongs to the Ophthalmic Decongestant/Antihistamine class of medications.
The FDA label lists Naphcon-A (pheniramine-naphazoline) as: ophthalmic route. Available strengths and packaging vary by manufacturer.
Yes. A generic version of Naphcon-A (pheniramine-naphazoline) is available in the U.S. Ask your pharmacist about substitution.
Our ingest of the FDA label for Naphcon-A (pheniramine-naphazoline) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Naphcon-A (pheniramine-naphazoline) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Naphcon-A (pheniramine-naphazoline) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA record lists the approval date for Naphcon-A (pheniramine-naphazoline) as 1994-06-08.
The FDA label lists Alcon Laboratories, Inc. as a labeler/manufacturer of Naphcon-A (pheniramine-naphazoline). Multiple firms may market generics of the same molecule.
Loading full data from Know Your Drugs Institute…